The CDR3 Region: A Pivotal Player in Antigen Recognition
The CDR3 region of antibodies plays a particularly pivotal role in the immune system's ability to combat pathogens.
Checkpoint inhibitors are a form of immunotherapy used to treat cancer.
The CDR3 region of antibodies plays a particularly pivotal role in the immune system's ability to combat pathogens.
Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) prevents overactivation of the immune system and averts potential damage to the body's own cells.
The immune system is responsible for defending the body against harmful microorganisms, foreign bodies, and dangerous substances.